Hungary and Russia are in advanced talks on licensing production of the Russian Sputnik V COVID-19 vaccine in Hungary, Reuters news agency reported on Tuesday.
Production under the deal could start from the end of 2022, Hungary's foreign minister said.
Hungary has widely used the Russian Sputnik vaccine during the pandemic even though it has not been approved by the European Medicines Agency.
Everest Medicines' EVM14 IND application receives US FDA approval
Clover Biopharmaceuticals' SCB-1019 IND application receives US FDA approval
Centivax partners with Emery Pharma on universal flu vaccine
Avance Biosciences registers with CLIA program
GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine
hVIVO secures GBP2m contract for final stage of hMPV characterisation study
EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine
Sanofi and J&J discontinue phase 3 study of E. coli vaccine candidate
Bain Capital to acquire Mitsubishi Tanabe Pharma in USD3.3bn deal
Valneva secures UK approval for world's first chikungunya vaccine
Anivive Lifesciences receives USD20m in funding from Leonid Capital Partners
ImmunityBio's ANKTIVA receives EMA review for BCG-unresponsive bladder cancer treatment
hVIVO signs LOI for landmark Phase 3 whooping cough vaccine trial with ILiAD Biotechnologies
Abyssinia Biosciences signs collaborative agreement with Cordance Medical